Skip to main content
Log in

Rifampicin in plasma and pleural fluid after single oral doses

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Single oral doses of rifampicin (RMP) were given to 31 patients with pleural effusions of various aetiologies. The concentrations of RMP and its active metabolites in pleural fluid and plasma were determined by an agar diffusion method using paper discs as diffusion centres. The plasma concentrations reached a peak within 3 h and then declined monoexponentially; in pleural fluid, RMP concentration rose slowly to reach a plateau that lasted for several hours. There were marked differences between subjects in the observed concentrations of RMP. During the first 12 h the plasma levels exceeded those in pleural fluid, but after 24 h the concentration of RMP in pleural fluid was higher than in plasma. If multiple oral doses of RMP 10 mg/kg b. w. are given every 24 h, as is common in the treatment of tuberculosis, therapeutic concentrations may be expected in pleural fluid for the major part of each day.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Malmborg, A.-S., Boman, G.: Rifampicin levels in pleural fluid. Adv. Antimicrob. Antineopl. Chemother., 123–125. München: Urban & Schwarzenberg 1972

    Google Scholar 

  2. Sensi, P., Maggi, N., Füresz, S., Maffii, G.: Chemical modifications and biological properties of rifamycins. Antimicrob. Agents Chemother. 1966, 699–714 (1967)

    Google Scholar 

  3. Experimental and clinical evaluation of the tuberculostatics. International Colloquium, Borstel, Germany, May 1968. Antibiot. Chemother.16. Basel: S. Karger 1970

  4. A Symposium on Rimactane, Basle, November 1968. Basel: Ciba Ltd.

  5. Symposium Européen Rifampicine, Pellenberg, Belgium, March 1969. Acta tuberc. pneumol. belg.60, 249–588 (1969)

  6. Rifampin in the treatment of pulmonary tuberculosis, Philadelphia, USA, October 1971. Chest61, 517–598 (1972)

  7. Furesz, S., Scotti, R., Pallanza, R., Mapelli, E.: Rifampicin: A new rifamycin. Arzneimittel-Forsch.17, 534–537 (1967)

    Google Scholar 

  8. Canetti, G., Parrot, R., Porven, G., LeLirzin, M.: Les taux de rifampicine dans le poumon et dans les lésions tuberculeuses de l'homme. Acta tuberc. pneumol. belg.60, 315–322 (1969)

    Google Scholar 

  9. Dettli, L.: The pharmacokinetics of Rimactane in patients with normal liver and kidney function. A Symposium on Rimactane, Basle, November 1968, p. 28–31. Basel: Ciba Ltd.

  10. Beeuwkes, H., Buytendijk, H.J., Maesen, F.P.V.: Der Wert des Rifampicin bei der Behandlung von Patienten mit bronchopulmonären Affektionen. Arzneimittel-Forsch.19, 1283–1285 (1969)

    Google Scholar 

  11. Rabinovici, A., Bocchino, M.: Sulla capacitá di passaggio della rifampicina in alcuni materiali organici. Riv. Pat. Clin. Tuberc.42, 329–334 (1969)

    Google Scholar 

  12. Chisholm, G.D., Waterworth, P.M., Calnan, J.S., Garrod, L.P.: Concentration of antibacterial agents in interstitial tissue fluid. Brit. med. J.1973 I, 569–573

    Google Scholar 

  13. Jalling, B., Malmborg, A.-S., Lindman, A., Boréus, L.O.: Evaluation of a micromethod for determination of antibiotic concentrations in plasma. Europ. J. clin. Pharmacol.4, 150–157 (1972)

    Google Scholar 

  14. Lundberg, C., Malmborg, A.-S.: Concentration of penicillin V and tetracycline in maxillary sinus secretion after repeated doses. Scand. J. infect. Dis.5, 123–133 (1973)

    Google Scholar 

  15. Canetti, G., Djurovic, V., LeLirzin, M., Thibier, R., Lepeuple, A.: Etude comparative de l'évolution des taux sanguins de rifampicine chez l'homme par deux méthodes microbiologiques différentes. Rev. Tuberc. (Paris)34, 93–106 (1970)

    Google Scholar 

  16. Lundberg, C., Malmborg, A.-S.: Concentration of penicillin and tetracycline in maxillary sinus secretion after a single dose. Scand. J. infect. Dis. In press (1973)

  17. Maggi, N., Furesz, S., Pallanza, R., Pelizza, G.: Rifampicin desacetylation in the human organism. Arzneimittel-Forsch.19, 651–654 (1969)

    Google Scholar 

  18. Finkel, J.M., Pittillo, R.F., Mellett, L.B.: Fluorometric and microbiological assays for rifampicin and the determination of serum levels in the dog. Chemotherapy (Basel)16, 380–388 (1971)

    Google Scholar 

  19. Kluge, T.: Absorpsjon fra de serøse huler. Nord. Med.82, 913–920 (1969)

    Google Scholar 

  20. Binda, G., Domenichini, E., Gottardi, A., Orlandi, B., Ortelli, E., Pacini, B., Fowst, G.: Rifampicin, a general review. Arzneimittel-Forsch.21, 1907–1978 (1971)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

A preliminary account of this paper was presented to the VIIth International Congress of Chemotherapy, Prague, 1971 (1)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boman, G., Malmborg, A.S. Rifampicin in plasma and pleural fluid after single oral doses. Eur J Clin Pharmacol 7, 51–58 (1974). https://doi.org/10.1007/BF00614390

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00614390

Key words

Navigation